Wensink, G Emerens; Elferink, Marloes A G; May, Anne M; Mol, Linda; Hamers, Patricia A H; Bakker, Sandra D; Creemers, Geert-Jan; de Groot, Jan Willem B; de Klerk, Gerty J; Haberkorn, Brigitte C M; Haringhuizen, Annebeth W; Hoekstra, Ronald; Hunting, J Cornelis B; Kerver, Emile D; Mathijssen-van Stein, Danielle; Polée, Marco B; Pruijt, Johannes F M; Quarles van Ufford-Mannesse, Patricia; Radema, Sandra; Rietbroek, Ronald C; Simkens, Lieke H J; Tanis, Bea C; Ten Bokkel Huinink, Daan; Tjin-A-Ton, Manuel L R; Tromp-van Driel, Cathrien S; Troost, Monique M; van de Wouw, Agnes J; van den Berkmortel, Franchette W P J; van der Pas, Anke J M; van der Velden, Ankie M T; van Dijk, Marjan A; van Dodewaard-de Jong, Joyce M; van Druten, Edith B; van Voorthuizen, Theo; Jan Veldhuis, Gerrit; Verheul, Henk M W; Vestjens, Hanneke J H M J; Vincent, Jeroen; Kranenburg, Onno W; Punt, Cornelis J A; Vink, Geraldine R; Roodhart, Jeanine M L; Koopman, Miriam
(Springer Nature, 2021-01)
BACKGROUND: Metastatic colorectal cancer patients with deficient mismatch repair (dMMR mCRC) benefit from immunotherapy. Interpretation of the single-arm immunotherapy trials is complicated by insignificant survival data ...